Medline Inc. is under investigation by Kaplan Fox & Kilsheimer LLP for potential securities violations following an FDA warning about significant manufacturing practice violations. The FDA highlighted failures in investigating batch discrepancies and microbial contamination, leading to a 7.16% drop in Medline's stock price. This is the second FDA action against Medline in two months, raising concerns about the company's compliance and quality controls. Investors who suffered losses or have information are encouraged to contact the law firm for potential legal action.
Medline Inc. and its recent regulatory issues are the subject, with Pluang's health sector data providing market context as of Sep 28, 2026 19:53 WIB. Among 100 priced health-sector US stocks tradable on Pluang, 23 rose and 64 fell today. Notable movers include Aurora Cannabis Inc (ACB) at USD 4.04 with a -1.46% change, BioNTech SE (BNTX) at USD 97.13 with a -1.41% change, and Enveric Biosciences Inc (ENVB) at USD 1.48 with a -1.33% change.
Grail's stock surged 55% in one week following a positive FDA advisory committee vote on its Galleri multi-cancer early detection test, which was deemed safe and beneficial. Analyst Kyle Mikson raised the price target from $80 to $150, reflecting str...
Qualcomm has renewed its Global Patent License Agreement with Apple, removing a major uncertainty for investors. The stock trades near $194 with a 24/7 Wall St. price target of $228.68, implying a 16.27% upside. Qualcomm's growth is driven by expandi...
McDonald's, the world's largest quick-service restaurant chain, has increased its dividend for 51 consecutive years, earning it the status of Dividend Aristocrat and Dividend King. The company has a solid financial position with an interest coverage ...
Fannie Mae announced fixed-price cash tender offers to repurchase various classes of Connecticut Avenue Securities (CAS) notes issued by its REMIC Trusts. The offers, which expire on October 2, 2026, allow noteholders to sell their securities back to...
Micron Technology's stock has surged 590% in the past year, reflecting high market expectations for growth amid a tightening memory chip market. Despite strong supply chain advantages, the company faces increasing competition, especially from Samsung...
